Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medisys buys Lukens Medical for $12.4 million:

This article was originally published in Clinica

Executive Summary

Medisys, the UK-based point-of-care device company, has agreed to pay $12.4 million for Lukens Medical, a wound closure and suture company. Nasdaq-quoted Lukens was founded in 1906 and has recently diversified into sharps disposal and lancets used in diabetes testing. Medisys regards the purchase as a cost-effective way to penetrate the US market. Medisys' diabetes subsidiary Hypoguard has been hit by increased competition and delays in new product launches.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts